Erratum: The triumph of medicine: How overdiagnosis is turning healthy people into patients [Family Practice 32, (2015) 127-128]. DOI:10.1093/fampra/cmv008;The triumph of medicine: How overdiagnosis is turning healthy people into patients

Family Practice

Volumn 32, Issue 2, 2015, Pages 127-128

  Van den Bruel, Ann ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULATION; CANCER SCREENING; CHRONIC KIDNEY DISEASE; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSIS; DIET RESTRICTION; DRUG INDUSTRY; EARLY DIAGNOSIS; EDITORIAL; GENERAL PRACTICE; HEALTH CARE; HEALTH INSURANCE; HEART INFARCTION; HUMAN; IMPAIRED GLUCOSE TOLERANCE; LIFE EXPECTANCY; LUNG ANGIOGRAPHY; LUNG EMBOLISM; MAMMOGRAPHY; MENTAL HEALTH; METASTASIS; NATIONAL HEALTH ORGANIZATION; OVERDIAGNOSIS; PAPILLARY CARCINOMA; PROSTATE CANCER; RISK FACTOR; WORLD HEALTH ORGANIZATION; BREAST NEOPLASMS; DIAGNOSTIC ERROR; DISEASE COURSE; FEMALE; MALE; PREDIABETIC STATE; UNNECESSARY PROCEDURE;

BREAST NEOPLASMS; DIAGNOSTIC ERRORS; DISEASE PROGRESSION; EARLY DIAGNOSIS; FEMALE; HUMANS; MALE; PREDIABETIC STATE; UNNECESSARY PROCEDURES;

EID: 84926615436     PISSN: 02632136     EISSN: 14602229     Source Type: Journal    
DOI: 10.1093/fampra/cmv033     Document Type: Erratum

References (23)

1. Welch HG, Black WC. Overdiagnosis in cancer. J Natl Cancer Inst 2010; 102: 605-13.
2. Harach HR, Franssila KO, Wasenius VM. Occult papillary carcinoma of the thyroid. A "normal" finding in Finland. A systematic autopsy study. Cancer 1985; 56: 531-8.
3. Etzioni R, Penson DF, Legler JM et al. Overdiagnosis due to prostate-specific antigen screening: lessons from U.S. prostate cancer incidence trends. J Natl Cancer Inst 2002; 94: 981-90.
4. American Diabetes Association. Standards of medical care in diabetes-2014. Diabetes Care 2014; 37: S14-80.
5. Yudkin JS, Montori VM. The epidemic of pre-diabetes: the medicine and the politics. BMJ2014; 349: g4485.
6. Ureña-Bogarín.....
7. Morris DH, Khunti K, Achana F et al. Progression rates from HbA1c 6.0-6.4% and other prediabetes definitions to type 2 diabetes: a meta-analysis. Diabetologia 2013; 56: 1489-93.
8. Knowler WC, Fowler SE, Hamman RF et al. 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study. Lancet 2009; 374: 1677-86.
9. Ghaye B. Peripheral pulmonary embolism on multidetector CT pulmonary angiography. JBR-BTR2007; 90: 100-8.
10. Wiener RS, Schwartz LM, Woloshin S. When a test is too good: how CT pulmonary angiograms find pulmonary emboli that do not need to be found. BMJ2013; 347: f3368.
11. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002; 39 (2 suppl 1): S1-S266.
12. Tiefer L. Female sexual dysfunction: a case study of disease mongering and activist resistance. PLoS Med 2006; 3: e178.
13. Moynihan R, Doust J, Henry D. Preventing overdiagnosis: how to stop harming the healthy. BMJ2012; 344: e3502.
14. Feinstein AR. The 'chagrin factor' and qualitative decision analysis. Arch Intern Med 1985; 145: 1257-9.
15. Kearon C, Akl EA, Comerota AJ et al. Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed:American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012; 141 (suppl 2): e419S-e94S.
16. Chou R, Croswell JM, Dana T et al. Screening for prostate cancer: a review of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med 2011; 155: 762-71.
17. Burgess C, Cornelius V, Love S, Graham J, Richards M, Ramirez A. Depression and anxiety in women with early breast cancer: five year observational cohort study. BMJ2005; 330: 702.
18. McCartney M. "Case finding" in dementia is simply screening with no evidence of benefit. BMJ2014; 349: g4791.
19. Gøtzsche PC, Jørgensen KJ. Screening for breast cancer with mammography. Cochrane Database Syst Rev 2013; 6: CD001877.
20. Chou R, Aronson N, Atkins D et al. AHRQ series paper 4: assessing harms when comparing medical interventions: AHRQ and the effective healthcare program. J Clin Epidemiol 2010; 63: 502-12.
21. Bossuyt PM, Reitsma JB, Linnet K, Moons KG. Beyond diagnostic accuracy:the clinical utility of diagnostic tests. Clin Chem 2012; 58: 1636-43.
22. World Health Organization. Definition and Diagnosis of Diabetes Mellitus and Intermediate Hyperglycemia: Report of a WHO/IDF Consultation. Geneva, Switzerland: World Health Organisation, 2006.
23. Esserman LJ, Thompson IM Jr, Reid B. Overdiagnosis and overtreatment in cancer: an opportunity for improvement. JAMA2013; 310: 797-8.